IL2 and asthma: This study investigated the activity of distinct NS preparations on asthma-related targets such as the release of IL-2, IL-6, and PGE2 from peripheral mononuclear human blood cells and a human epithelial cell line (A549) to provide the basis of a clinical study (Koshak et al., 2017b).